CorMedix Inc. (CRMD)

CorMedix Stock Forecast

Stock Price Forecast

The 7 analysts that cover CorMedix stock have a consensus rating of "Strong Buy" and an average price target of $17.33, which forecasts a 52.02% increase in the stock price over the next year. The lowest target is $12 and the highest is $20.

Price Target: $17.33 (+52.02%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$17.33	$18	$20
Change	+5.26%	+52.02%	+57.89%	+75.44%

Analyst Ratings

The average analyst rating for CorMedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	4	4	4	3
Buy	2	2	3	3	2	3
Hold	0	0	0	0	0	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	7	7	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jun 30, 2025
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $20	Strong Buy	Initiates	$20	+75.44%	Jun 30, 2025
Serge Belanger Needham	Needham	Strong Buy Maintains $15 → $20	Strong Buy	Maintains	$15 → $20	+75.44%	Jun 24, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $15	Strong Buy	Maintains	$15	+31.58%	Jun 23, 2025
Leonid Timashev RBC Capital	RBC Capital	Buy Reiterates $13 → $17	Buy	Reiterates	$13 → $17	+49.12%	Jun 20, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

147.10M

Increased by 238.38%

from 43.47M

Revenue Next Year

225.83M

Increased by 53.52%

from 147.10M

EPS This Year

0.81

from -0.30

EPS Next Year

1.54

Increased by 88.94%

from 0.81

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	239.23K	190.94K	65.41K	-	43.47M	147.10M	225.83M	279.07M
Revenue Growth	-15.55%	-20.19%	-65.74%	-	-	238.38%	53.52%	23.58%
EPS	-0.77	-0.75	-0.74	-0.91	-0.30	0.81	1.54	2.05
EPS Growth	-	-	-	-	-	-	88.94%	33.26%
Forward PE	-	-	-	-	-	14.00	7.41	5.56
No. Analysts	-	-	-	-	-	8	8	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	181.6M	293.3M	366.1M
Avg	147.1M	225.8M	279.1M
Low	125.4M	147.2M	134.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	317.6%	99.4%	62.1%
Avg	238.4%	53.5%	23.6%
Low	188.6%	0.1%	-40.3%

EPS Forecast

EPS	2025	2026	2027
High	1.24	2.23	2.85
Avg	0.81	1.54	2.05
Low	0.49	0.79	0.68

EPS Growth

EPS Growth	2025	2026	2027
High	-	173.4%	85.0%
Avg	-	88.9%	33.3%
Low	-	-2.5%	-56.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.